Clindamycin Palmitate Hydrochloride recalls
Clindamycin Palmitate Hydrochloride products have been recalled 1 time, most recently on 19 Aug 2026. The recalling company is usually Heritage Pharmaceuticals. The most common reason is particulate matter.
Total recalls1since 2026
Last 12 months1reported
Class I00% of total
Ongoing1latest 19 Aug 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why clindamycin palmitate hydrochloride is recalled
Companies
Product types
By year
Ongoing clindamycin palmitate hydrochloride recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Clindamycin Palmitate Hydrochloride For Oral Solution, USP, 75 mg recalledClindamycin Palmitate Hydrochloride | Heritage Pharmaceuticals | Particulate Matter | Nationwide |
All clindamycin palmitate hydrochloride recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Clindamycin Palmitate Hydrochloride For Oral Solution, USP, 75 mg recalledClindamycin Palmitate Hydrochloride | Heritage Pharmaceuticals | Particulate Matter | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.